Literature DB >> 12007955

Trends in, and predictors of, breast-conserving surgery and radiotherapy for breast cancer in Connecticut, 1988-1997.

Anthony P Polednak1.   

Abstract

PURPOSE: To describe the trends in, and predictors of, use of breast-conserving surgery (BCS) vs. mastectomy and use of post-BCS radiotherapy (RT), from 1988 through 1997 among residents of Connecticut. METHODS AND MATERIALS: Data on surgical and RT procedures for 16,676 women diagnosed with early-stage (localized to the breast or with regional lymph node involvement) invasive breast cancer in 1988-1997 were obtained from the population-based Connecticut Tumor Registry.
RESULTS: Use of BCS (vs. mastectomy) increased over time and was lower for patients with nodal involvement or larger tumors. The absence of RT facilities at the hospital of first admission was negatively associated with BCS but not with post-BCS RT. Post-BCS RT was low among patients diagnosed at age 80+ years but increased over time only in this age group.
CONCLUSION: Absence of RT at the hospital may be a deterrent to BCS. The temporal increase in post-BCS RT among patients diagnosed at age > or =80 years suggests changes in physicians' attitudes and/or patient preferences that require further study.

Entities:  

Mesh:

Year:  2002        PMID: 12007955     DOI: 10.1016/s0360-3016(01)02829-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

Review 1.  Tumor Bed Boost Integration during Whole Breast Radiotherapy: A Review of the Current Evidence.

Authors:  Pierfrancesco Franco; Domenico Cante; Piera Sciacero; Giuseppe Girelli; Maria Rosa La Porta; Umberto Ricardi
Journal:  Breast Care (Basel)       Date:  2015-02       Impact factor: 2.860

2.  Risk of cardiac death after adjuvant radiotherapy for breast cancer.

Authors:  Sharon H Giordano; Yong-Fang Kuo; Jean L Freeman; Thomas A Buchholz; Gabriel N Hortobagyi; James S Goodwin
Journal:  J Natl Cancer Inst       Date:  2005-03-16       Impact factor: 13.506

3.  Completion of adjuvant radiation therapy among women with breast cancer.

Authors:  Tomasz P Srokowski; Shenying Fang; Zhigang Duan; Thomas A Buchholz; Gabriel N Hortobagyi; James S Goodwin; Sharon H Giordano
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

4.  Patterns of Failure Observed in the 2-Step Institution Credentialing Process for NRG Oncology/Radiation Therapy Oncology Group 1005 (NCT01349322) and Lessons Learned.

Authors:  X Allen Li; Jennifer Moughan; Julia R White; Gary M Freedman; Douglas W Arthur; James Galvin; Ying Xiao; Susan McNulty; Janice A Lyons; Vivek S Kavadi; Marc T Fields; Melissa P Mitchell; Bethany M Anderson; Michael I Lock; Kristine E Kokeny; Jose G Bazan; Adam D Currey; Tarek Hijal; Sally B Cheston; Frank A Vicini
Journal:  Pract Radiat Oncol       Date:  2019-11-29

5.  Impact of acculturation on breast cancer treatment and survivorship care among Mexican American patients in Texas.

Authors:  Pragati Advani; Melissa Bondy; Patricia A Thompson; María Elena Martínez; Jesse N Nodora; Sally W Vernon; Pamela Diamond; Jason Burnett; Abenaa M Brewster
Journal:  J Cancer Surviv       Date:  2018-07-25       Impact factor: 4.442

6.  Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer.

Authors:  Gary M Freedman; Penny R Anderson; Richard J Bleicher; Samuel Litwin; Tianyu Li; Ramona F Swaby; Chang-Ming Charlie Ma; Jinsheng Li; Elin R Sigurdson; Deborah Watkins-Bruner; Monica Morrow; Lori J Goldstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-12       Impact factor: 7.038

7.  A comparative study on hypofractionated whole-breast irradiation with sequential or simultaneous integrated boost on different positions after breast-conserving surgery.

Authors:  Ting Yu; Yankang Li; Tao Sun; Min Xu; Wei Wang; Qian Shao; Yingjie Zhang; Jianbin Li; Jinming Yu
Journal:  Sci Rep       Date:  2021-09-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.